Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.33 USD | +7.96% | +27.39% | +68.13% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.13% | 14.68M | |
+1.43% | 43.84B | |
+6.72% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+7.58% | 25.53B | |
-24.46% | 18.18B | |
-3.19% | 12.29B | |
+27.75% | 12.29B | |
+7.74% | 11.15B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Therapeutics Appoints Chief Commercial Officer